Living Donor Liver Transplantation for Neoadjuvant-Treated, Unresectable Intrahepatic Cholangiocarcinoma (LIVINCA): Study Protocol for a One-Armed, Monocentric, Non-Randomized Trial
The design of the LIVINCA study may provide patients with otherwise unresectable intrahepatic cholangiocarcinoma a chance for a curative treatment option. This procedure does not reduce the deceased donor organ supply because living donation is the primary treatment option in these patients.
Authors
- Aladdin Ali Deeb (ORCID: https://orcid.org/0000-0001-9568-8837)
- Felix Dondorf (ORCID: https://orcid.org/0000-0002-3569-938X)
- Utz Settmacher (ORCID: https://orcid.org/0000-0003-2417-7196)
- Oliver Rohland (ORCID: https://orcid.org/0009-0003-2597-6464)
- Laura Schwenk (ORCID: https://orcid.org/0009-0002-8056-0800)
- Falk Rauchfuß (ORCID: https://orcid.org/0000-0002-9017-2601)
Institutions
- Jena University Hospital (DE)
Publication Details
- Journal
- Oncology Research and Treatment
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1159/000545871
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00